Pharma QC
Fujifilm and HORIBA Co-Develop High-Sensitivity Inline Raman System to Enhance Biopharmaceutical Manufacturing
FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) and HORIBA, Ltd. (President: Masayuki Adachi) announced the co-development ...
June 18, 2026 | News
Pelago Bioscience Acquires RG Discovery to Create Integrated Chemistry-to-Biology Drug Discovery Platform
Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement as...
June 17, 2026 | News
Akeso Expands Immunology Franchise with Approval of Gumokimab for Psoriasis
Akeso, Inc. announced that the National Medical Products Administration (NMPA) of China has approved gumokimab (AK111), the company's internally-devel...
June 15, 2026 | News
Matten Launches Southeast Asia’s First Membrane-Based Cold WFI System for Pharmaceutical Manufacturing
MattenPlant Pte Ltd (Matten) a Singapore-based specialist in industrial and municipal water and wastewater treatment, announces the launch of it...
June 12, 2026 | News
Duke-NUS Secures €2 Million EU Grant to Expand Wastewater Surveillance Across Asia
EU-funded project will help countries build early-warning systems to spot infectious disease threats before clinical cases surge Duke-NUS Medical School h...
June 11, 2026 | News
Waters Launches Coin Cell DSC to Advance Battery Safety Testing and Thermal Analysis
Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whol...
June 11, 2026 | News
PromptBio Launches Agentic AI Platform to Accelerate Scientific Discovery
The PromptBio Platform combines conversational AI with multi-agent orchestration to accelerate discovery from hypotheses to insights PromptBio, a Californ...
June 11, 2026 | News
Formation Bio Doses First Participant in Phase I Trial of Lynk’s CNS-Penetrant TYK2 Inhibitor
Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseas...
June 12, 2026 | News
Can the 'Pharmacy of the World' Survive Its Own Scandals?
In late September and early October 2025, children in the central Indian state of Madhya Pradesh began arriving at hospitals with the same grim trajectory:...
June 08, 2026 | Analysis
Pierre Fabre Laboratories Receives CHMP Positive Opinion For BRAFTOVI Combination In First Line BRAF Mutant Metastatic Colorectal Cancer
This positive CHMP opinion is based on results from the Phase 3 BREAKWATER trial, which showed that encorafenib in combination w...
May 27, 2026 | News
Ingenia Therapeutics Secures KRX Approval For IPO Amid Advancing TIE2 Targeted Pipeline
Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has receive...
May 26, 2026 | News
Hyundai Bioscience Positions XAFTY As Potential Ebola And Hantavirus Treatment Following Strong IC50 Findings
Ebola IC50 (0.125μM)—Strong inhibition at less than half the concentration of the clinically-tested COVID-19 (0.28μM). Clinical safety confi...
May 22, 2026 | News
KBP Biosciences Says Singapore Court Made No Fraud Finding In Ongoing Novo Nordisk Arbitration
KBP Biosciences Pte. Ltd. issued a statement addressing the decision by the Singapore Court of Appeal to maintain the temporary injunction against the Comp...
May 22, 2026 | News
CHEPLAPHARM Group Advances AI Ready Supply Chain Transformation Through TraceLink Network Integration
The German pharmaceutical company unifies its digital partner network, laying the foundation for AI-driven supply chain orchestration TraceLink, the world...
May 18, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
